Cvs Health (CVS) EPS (Basic) (2009 - 2026)

Cvs Health (CVS) has reported EPS (Basic) for 18 consecutive years, with $2.34 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) rose 192.65% year-over-year to $2.34; the trailing twelve-month figure through Jun 2026 stood at $3.82 (up 7.72% YoY), and the FY2025 full-year result was $1.36, down 62.56% from the prior year.
• EPS (Basic) improved to $2.34 in Q2 2026 per CVS's latest filing, from $2.32 in the prior quarter.
• Across five years, EPS (Basic) topped out at $2.34 in Q2 2026 and bottomed at -$3.14 in Q3 2025.
• Historically, EPS (Basic) has averaged $1.08 across 5 years, with a median of $1.54 in 2023.
• The sharpest annual moves came in 2025 and 2026: EPS (Basic) tumbled 5675.43% in 2025, then jumped 192.65% in 2026.
• Over 5 years, EPS (Basic) stood at $1.78 in 2022, then dropped by 10.38% to $1.59 in 2023, then dropped by 19.08% to $1.29 in 2024, then jumped by 78.96% to $2.31 in 2025, then gained by 1.5% to $2.34 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $2.34, $2.32, and $2.31 for Q2 2026, Q1 2026, and Q4 2025 respectively.